{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:48:08Z","timestamp":1792439288358,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR074530"],"award-info":[{"award-number":["K23AR074530"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jaad.2021.04.077","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:50:58Z","timestamp":1619783458000},"page":"1318-1334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Treatment of pediatric alopecia areata: A systematic review"],"prefix":"10.1016","volume":"86","author":[{"given":"Virginia R.","family":"Barton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atrin","family":"Toussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Kiuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2011.01476.x","article-title":"Advances in the management of alopecia areata","volume":"39","author":"Ito","year":"2012","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000466704","article-title":"Bullying and quality of life in pediatric alopecia areata","volume":"3","author":"Christensen","year":"2017","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib123","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaad.2017.05.034","article-title":"Lack of efficacy of apremilast in 9 patients with severe alopecia areata","volume":"77","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"10.1016\/j.jaad.2021.04.077_bib124","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1524-4725.2010.01709.x","article-title":"Treatment effects of intradermal botulinum toxin type A injection on alopecia areata","volume":"36","author":"Cho","year":"2010","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09546630600895003","article-title":"Determination of the sildenafil effect on alopecia areata in childhood: an open-pilot comparison study","volume":"17","author":"Sarifakioglu","year":"2006","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1754.2003.00116.x","article-title":"Coeliac disease and alopecia areata in childhood","volume":"39","author":"Fessatou","year":"2003","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib127","first-page":"59","article-title":"Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis","volume":"17","author":"Boonyaleepun","year":"1999","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib128","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1442-200X.1990.tb00879.x","article-title":"Successful bone marrow transplant and re-growth of hair in a patient with posthepatic aplastic anemia complicated by alopecia totalis","volume":"32","author":"Shibuya","year":"1990","journal-title":"Acta Paediatr Jpn"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.077_bib129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.62.8.778","article-title":"Alopecia areata and relapsing polychondritis or mosaic autoimmunity? The first experience of co-trimoxazole treatment","volume":"62","author":"Rozin","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-4362.1973.tb00215.x","article-title":"Use of aloe in treating leg ulcers and dermatoses","volume":"12","author":"Zawahry","year":"1973","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.0022-202X.2005.10130_6.x","article-title":"Treatment of alopecia areata with anti-interferon-gamma antibodies","volume":"10","author":"Skurkovich","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib132","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2005.09.025","article-title":"Hypnotherapeutic management of alopecia areata","volume":"55","author":"Willemsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib133","first-page":"138","article-title":"Imiquimod in the treatment of alopecia universalis","volume":"79","author":"Letada","year":"2007","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0190-9622(05)80001-5","article-title":"Psychotherapy for intractable inflammatory dermatoses","volume":"32","author":"Koblenzer","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.jaad.2021.04.077_bib135","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2466\/pr0.1994.74.3c.1315","article-title":"A case study: massage, relaxation, and reward for treatment of alopecia areata","volume":"74","author":"Putt","year":"1994","journal-title":"Psychol Rep"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib136","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000288561","article-title":"Application of psychoimmunotherapy in patients with alopecia universalis","volume":"56","author":"Teshima","year":"1991","journal-title":"Psychother Psychosom"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.077_bib137","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-4362.1985.tb05864.x","article-title":"Treatment of alopecia areata with topical nitrogen mustard","volume":"24","author":"Arrazola","year":"1985","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/pde.13688","article-title":"Recalcitrant alopecia areata responsive to leflunomide and anthralin-potentially undiscovered JAK\/STAT inhibitors?","volume":"35","author":"Sardana","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/pde.13703","article-title":"Treatment of pediatric alopecia areata with anthralin: a retrospective study of 37 patients","volume":"35","author":"Wu","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/pde.13049","article-title":"Bilateral half-head comparison of 1% anthralin ointment in children with alopecia areata","volume":"34","author":"\u00d6zdemir","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1525-1470.2010.01191.x","article-title":"Bilateral treatment for alopecia areata","volume":"27","author":"Torchia","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/ajd.12478","article-title":"Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: an observational study of nonresponder patients with alopecia areata","volume":"58","author":"Wasylyszyn","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib10","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/jdv.12009","article-title":"Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata","volume":"27","author":"Luk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.077_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archdermatol.2012.1622","article-title":"The safety and efficacy of diphencyprone for the treatment of alopecia areata in children","volume":"148","author":"Salsberg","year":"2012","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4103\/0378-6323.37072","article-title":"Diphenylcyclopropenone immunotherapy in ophiasis","volume":"73","author":"Singh","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib15","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2133.1996.d01-1044.x","article-title":"Alopecia areata in children: treatment with diphencyprone","volume":"135","author":"Schuttelaar","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2133.1991.tb06064.x","article-title":"Alopecia areata in children: response to treatment with diphencyprone","volume":"125","author":"Hull","year":"1991","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000249418","article-title":"Treatment of alopecia areata with diphencyprone","volume":"171","author":"Orecchia","year":"1985","journal-title":"Dermatologica"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib21","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/pde.12993","article-title":"Angioedema after squaric acid treatment in a 6-year-old girl","volume":"34","author":"Chen","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bjd.14764","article-title":"Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata","volume":"176","author":"Guerra","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2021.04.077_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","article-title":"Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis","volume":"35","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2021.04.077_bib19","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1038\/jid.1995.53","article-title":"Topical immunotherapy in children with alopecia areata","volume":"104","author":"Orecchia","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000249797","article-title":"Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester","volume":"167","author":"Giannetti","year":"1983","journal-title":"Dermatologica"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1346-8138.13613","article-title":"Efficacy and safety of superficial cryotherapy for alopecia areata: a retrospective, comprehensive review of 353 cases over 22 years","volume":"44","author":"Jun","year":"2017","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2229-5178.202269","article-title":"Minoxidil-induced hypertrichosis in a child with alopecia areata","volume":"8","author":"Rai","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2021.04.077_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.11604\/pamj.2014.18.8.3637","article-title":"Minoxidil induced hypertrichosis in children","volume":"18","author":"Guerouaz","year":"2014","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jaad.2021.04.077_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.12688\/f1000research.2-226.v1","article-title":"Minoxidil induced hypertrichosis in a 2 year-old child","volume":"2","author":"Herskovitz","year":"2013","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000096924","article-title":"Topical use of minoxidil in children and systemic side effects","volume":"214","author":"Georgala","year":"2007","journal-title":"Dermatology"},{"issue":"2 suppl 1","key":"10.1016\/j.jaad.2021.04.077_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaad.2004.06.024","article-title":"Congenital alopecia areata","volume":"52","author":"Lenane","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-4362.1989.tb01340.x","article-title":"Minoxidil and tail-like effect","volume":"28","author":"Baral","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2021.04.077_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(81)80077-1","article-title":"Topical minoxidil in alopecia areata","author":"Weiss","year":"1981","journal-title":"JAAD"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.077_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/ijd.13676","article-title":"Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata","volume":"56","author":"Jung","year":"2017","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2230.2007.02367.x","article-title":"Lack of response of alopecia areata to pimecrolimus cream","volume":"32","author":"Rigopoulos","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"issue":"14","key":"10.1016\/j.jaad.2021.04.077_bib44","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0009922816678185","article-title":"Alopecia areata in an adolescent with inflammatory bowel disease","volume":"56","author":"Sankararaman","year":"2017","journal-title":"Clin Pediatr"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/dth.12255","article-title":"Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study","volume":"28","author":"Lalosevic","year":"2015","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2013.5764","article-title":"Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial","volume":"150","author":"Lenane","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0560.1977.tb00889.x","article-title":"Topical halcinonide in alopecia areata and in alopecia totalis","volume":"4","author":"Montes","year":"1977","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2021.04.077_bib46","first-page":"419","article-title":"An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects","volume":"10","author":"Borchert","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib48","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/pde.12920","article-title":"Successful treatment of pediatric alopecia areata of the scalp using topical bimatoprost","volume":"33","author":"Li","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib47","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1111\/j.1365-2230.2009.03755.x","article-title":"Successful use of bimatoprost in the treatment of alopecia of the eyelashes","volume":"35","author":"Zaheri","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.077_bib50","doi-asserted-by":"crossref","first-page":"e1010","DOI":"10.1111\/j.1365-2230.2009.03677.x","article-title":"An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2","volume":"34","author":"Yadav","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.eye.6700354","article-title":"Cutaneous latanoprost in the treatment of alopecia areata","volume":"17","author":"Mehta","year":"2003","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/1346-8138.13533","article-title":"Intramuscular triamcinolone acetonide: an undervalued option for refractory alopecia areata","volume":"44","author":"Seo","year":"2017","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000066435","article-title":"Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis","volume":"205","author":"Sato-Kawamura","year":"2002","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00455378","article-title":"Long-term intramuscular triamcinolon-acetonide therapy in alopecia areata totalis and universalis","volume":"261","author":"Michalowski","year":"1978","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000441250","article-title":"Efficacy and safety of methotrexate combined with low- to moderate-dose corticosteroids for severe alopecia areata","volume":"232","author":"Anuset","year":"2016","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib55","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/jidsymp.2013.23","article-title":"Clinical response to combined therapy of cyclosporine and prednisone","volume":"16","author":"Gensure","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1525-1470.1999.pdele65.x","article-title":"Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood","volume":"16","author":"Camacho","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.077_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-4362.1998.00422.x","article-title":"Severe alopecia areata treated with systemic corticosteroids","volume":"37","author":"Alabdulkareem","year":"1998","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.077_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/21548331.1987.11703313","article-title":"The boy whose hair came back","volume":"22","author":"Schindler","year":"1987","journal-title":"Hosp Pract"},{"issue":"10","key":"10.1016\/j.jaad.2021.04.077_bib72","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/archderm.1978.01640220035008","article-title":"Corticosteroids in the treatment of alopecia totalis. Systemic effects","volume":"114","author":"Unger","year":"1978","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.077_bib73","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.1976.01630350025006","article-title":"Prednisone therapy for alopecia areata. A follow-up report","volume":"112","author":"Winter","year":"1976","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.04.077_bib53","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1111\/jdv.14291","article-title":"High-dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood","volume":"31","author":"Chong","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ddg.12875","article-title":"Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata","volume":"15","author":"Jahn-Bassler","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/pde.12578","article-title":"High relapse rates despite early intervention with intravenous methylprednisolone pulse therapy for severe childhood alopecia areata","volume":"32","author":"Smith","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000351559","article-title":"Pulse corticosteroid therapy for alopecia areata in children: a retrospective study","volume":"227","author":"Friedland","year":"2013","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000339341","article-title":"Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series","volume":"224","author":"Droitcourt","year":"2012","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0031-1273703","article-title":"Successful immunsuppression in childhood alopecia areata","volume":"223","author":"Sauerbrey","year":"2011","journal-title":"Klin Padiatr"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib60","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2008.08458.x","article-title":"Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy","volume":"158","author":"Hubiche","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0378-6323.29346","article-title":"Alopecia universalis in Down syndrome: response to therapy","volume":"72","author":"Sethuraman","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib67","first-page":"717","article-title":"Oral mega pulse methylprednisolone in alopecia universalis","volume":"27","author":"Bin Saif","year":"2006","journal-title":"Saudi Med J"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib62","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000051642","article-title":"High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata","volume":"202","author":"Seiter","year":"2001","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.jaad.2021.04.077_bib68","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","article-title":"Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata","volume":"26","author":"Sharma","year":"1999","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1525-1470.1998.tb01348.x","article-title":"Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse","volume":"15","author":"Sharma","year":"1998","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000246159","article-title":"Pulse steroid therapy for children's severe alopecia areata?","volume":"194","author":"Kiesch","year":"1997","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000247268","article-title":"Pulse of methylprednisolone in alopecia areata","volume":"187","author":"Perriard-Wolfensberger","year":"1993","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/pde.13451","article-title":"Alopecia areata treated with hydroxychloroquine: a retrospective study of nine pediatric cases","volume":"35","author":"Yun","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.077_bib83","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1111\/jdv.15834","article-title":"Azathioprine in combination with methotrexate: a therapeutic alternative in severe and recalcitrant forms of alopecia areata?","volume":"33","author":"Mascia","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09546634.2017.1341608","article-title":"Methotrexate for the treatment of pediatric alopecia areata","volume":"29","author":"Landis ET, Pichardo-Geisinger","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib79","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/ijt.ijt_67_16","article-title":"Methotrexate in alopecia areata: a report of three cases","volume":"8","author":"Batalla","year":"2016","journal-title":"Int J Trichology"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/00015555-2173","article-title":"Methotrexate in severe childhood alopecia areata: long-term follow-up","volume":"96","author":"Lucas","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","article-title":"Efficacy and tolerability of methotrexate in severe childhood alopecia areata","volume":"165","author":"Royer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/ijt.ijt_14_18","article-title":"Mesalazine in the treatment of extensive alopecia areata: a new therapeutic option?","volume":"10","author":"Kiszewski","year":"2018","journal-title":"Int J Trichology"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.077_bib87","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-4632.2008.03700.x","article-title":"Treatment of persistent alopecia areata with sulfasalazine","volume":"47","author":"Rashidi","year":"2008","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaad.2006.10.980","article-title":"Is there a role for sulfasalazine in the treatment of alopecia areata?","volume":"57","author":"Bakar","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib90","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/pde.13699","article-title":"Response to ustekinumab in three pediatric patients with alopecia areata","volume":"36","author":"Aleisa","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib91","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaci.2019.08.014","article-title":"IL-12\/IL-23 neutralization is ineffective for alopecia areata in mice and humans","volume":"144","author":"Ortolan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib95","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib99","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaad.2018.08.041","article-title":"Tofacitinib for the treatment of alopecia areata in preadolescent children","volume":"80","author":"Craiglow","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib101","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jaad.2018.12.041","article-title":"Tofacitinib therapy for children with severe alopecia areata","volume":"80","author":"Dai","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.04.077_bib98","first-page":"914","article-title":"An excellent response to tofacitinib in a pediatric alopecia patient: a case report and review","volume":"17","author":"Brown","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib102","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1203475418760512","article-title":"A case report highlighting the effective treatment of alopecia universalis with tofacitinib in an adolescent and adult patient","volume":"22","author":"Patel","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib97","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaad.2016.11.038","article-title":"Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis","volume":"76","author":"Castelo-Soccio","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib96","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jaad.2018.08.040","article-title":"Ruxolitinib for the treatment of severe alopecia areata","volume":"80","author":"Liu","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib105","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaad.2018.02.031","article-title":"Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis","volume":"78","author":"Putterman","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaad.2017.03.024","article-title":"Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata","volume":"77","author":"Bayart","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","article-title":"Topical ruxolitinib for the treatment of alopecia universalis","volume":"152","author":"Craiglow","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/14764172.2017.1383617","article-title":"Association of khellin and 308-nm excimer lamp in the treatment of severe alopecia areata in a child","volume":"20","author":"Fenniche","year":"2018","journal-title":"J Cosmet Laser Ther"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib107","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","article-title":"308-nm excimer laser for the treatment of alopecia areata in children","volume":"26","author":"Al-Mutairi","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.077_bib106","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","article-title":"308-nm excimer laser therapy in alopecia areata","volume":"51","author":"Zakaria","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","article-title":"Narrowband ultraviolet B (UVB) phototherapy in children","volume":"31","author":"Jury","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib112","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1525-1470.2008.00773.x","article-title":"Phototherapy in childhood","volume":"25","author":"Ersoy-Evans","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.077_bib115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1365-4632.2005.02542.x","article-title":"Infant alopecia universalis: role of topical PUVA (psoralen ultraviolet A) radiation","volume":"44","author":"Yoon","year":"2005","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib114","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0190-9622(85)70088-6","article-title":"Topical photochemotherapy for alopecia areata","volume":"12","author":"Mitchell","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.04.077_bib111","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archderm.1983.01650360021007","article-title":"PUVA treatment of alopecia areata","volume":"119","author":"Claudy","year":"1983","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-4362.1983.tb03377.x","article-title":"Photochemotherapy and alopecia areata","volume":"22","author":"Amer","year":"1983","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/dth.12215","article-title":"Combination therapy with zinc gluconate and PUVA for alopecia areata totalis: an adjunctive but crucial role of zinc supplementation","volume":"28","author":"Lux-Battistelli","year":"2015","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2021.04.077_bib117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/ijt.ijt_95_17","article-title":"\u201cTurban PUVAsol:\u201d A simple, novel, effective, and safe treatment option for advanced and refractory cases of alopecia areata","volume":"10","author":"Majumdar","year":"2018","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib116","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000254489","article-title":"Local estrogen and ultraviolet irradiation in the treatment of total alopecia (areata)","volume":"131","author":"Belezos","year":"1965","journal-title":"Dermatologica"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib8","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/jidsymp.2013.14","article-title":"Current treatment of alopecia areata","volume":"16","author":"Shapiro","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"10","key":"10.1016\/j.jaad.2021.04.077_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamadermatol.2018.2312","article-title":"Hair regrowth outcomes of contact immunotherapy for patients with alopecia areata: a systematic review and meta-analysis","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0974-7753.66911","article-title":"Topical immunotherapy in alopecia areata","volume":"2","author":"Singh","year":"2010","journal-title":"Int J Trichology"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0974-7753.179403","article-title":"Liquid nitrogen cryotherapy in recalcitrant alopecia areata: a study of 11 patients","volume":"8","author":"Zawar","year":"2016","journal-title":"Int J Trichology"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","article-title":"Off-label use of topical minoxidil in alopecia: a review","volume":"20","author":"Stoehr","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2021.04.077_bib34","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1087-0024.2003.00811.x","article-title":"Therapy of alopecia areata: on the cusp and in the future","volume":"8","author":"Price","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-7753.66920","article-title":"Intralesional steroids for alopecia areata","volume":"2","author":"Kumaresan","year":"2010","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1016\/j.jaad.2021.04.077_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis","volume":"24","author":"Coronel-P\u00e9rez","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaad.2015.09.045","article-title":"A systematic review of pulse steroid therapy for alopecia areata","volume":"74","author":"Shreberk-Hassidim","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib78","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4161\/derm.1.6.11236","article-title":"Medium-dose prednisolone pulse therapy in alopecia areata","volume":"1","author":"Efentaki","year":"2009","journal-title":"Dermatoendocrinol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib84","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","article-title":"Methotrexate for alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Phan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib88","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/0378-6323.45103","article-title":"An uncontrolled, open label study of sulfasalazine in severe alopecia areata","volume":"74","author":"Aghaei","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"10169","key":"10.1016\/j.jaad.2021.04.077_bib92","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2021.04.077_bib94","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the Janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2021.04.077_bib119","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14764172.2016.1248440","article-title":"A review on laser and light-based therapies for alopecia areata","volume":"19","author":"Mlacker","year":"2017","journal-title":"J Cosmet Laser Ther"},{"issue":"5","key":"10.1016\/j.jaad.2021.04.077_bib120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists' guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.04.077_bib121","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.clindermatol.2015.09.005","article-title":"Alopecia: kids are not just little people","volume":"33","author":"Goldberg","year":"2015","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.04.077_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijwd.2017.11.002","article-title":"The impact of pediatric skin disease on self-esteem","volume":"4","author":"Vivar","year":"2018","journal-title":"Int J Womens Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:04:21Z","timestamp":1759273461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221009221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0190962221009221"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.077","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740050083.793598020","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pediatric alopecia areata: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}